Kim Frieze, PharmD

Senior Vice President, Medical Communications

Kimberly A. Frieze, PharmD has a career spanning decades in clinical research, regulatory affairs, and regulatory writing for drug and biologic products. Before joining InClin, she served as Director of Medical Writing at Cardinal Health Regulatory Sciences (formerly Beckloff Associates), where she led a large writing team and contributed to numerous regulatory submissions during her tenure, including INDs, NDAs, BLAs, and ANDAs. Her previous roles include Principal Medical Writing Scientist at Quintiles and Senior Medical Writer/Senior Clinical Research Associate at Hoechst Marion Roussel. Prior to transitioning into industry, Dr. Frieze practiced as a clinical oncology pharmacist. She is a registered pharmacist in Kansas and a member of the American Medical Writers Association (AMWA). Dr. Frieze holds both a Doctor of Pharmacy and a Bachelor of Pharmacy from the University of Kansas School of Pharmacy.